[
  {
    "ts": null,
    "headline": "Here’s Headwaters Capital Management’s Investment Thesis for Bio-Techne (TECH)",
    "summary": "Headwaters Capital Management, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The portfolio bounced back from the first quarter uncertainty and, like the rest of the market, experienced a strong rebound after the tariff-induced sell-off at the start of the quarter. The portfolio gained […]",
    "url": "https://finnhub.io/api/news?id=1e431cb5dc27e4ff534479836052ada1081ff47a515628b803bcde3f9665a3fd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752588556,
      "headline": "Here’s Headwaters Capital Management’s Investment Thesis for Bio-Techne (TECH)",
      "id": 135966608,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Headwaters Capital Management, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The portfolio bounced back from the first quarter uncertainty and, like the rest of the market, experienced a strong rebound after the tariff-induced sell-off at the start of the quarter. The portfolio gained […]",
      "url": "https://finnhub.io/api/news?id=1e431cb5dc27e4ff534479836052ada1081ff47a515628b803bcde3f9665a3fd"
    }
  },
  {
    "ts": null,
    "headline": "Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology",
    "summary": "WOBURN, Mass., July 15, 2025--Spear Bio, a biotechnology company pioneering homogeneous ultrasensitive immunoassay technology, is pleased to announce a strategic distribution partnership with Bio-Techne Corporation (NASDAQ: TECH), a global leading provider of innovative reagents, instruments, and solutions for life-science research and clinical diagnostics. The partnership significantly expands global access to Spear Bio’s groundbreaking SPEAR UltraDetect™ immunoassays, focusing initially on the",
    "url": "https://finnhub.io/api/news?id=bf3be4c7691874495c8529b80e789aec9f66aa62fc867c8ddfb0b92a4d675e0a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752584580,
      "headline": "Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology",
      "id": 135966609,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "WOBURN, Mass., July 15, 2025--Spear Bio, a biotechnology company pioneering homogeneous ultrasensitive immunoassay technology, is pleased to announce a strategic distribution partnership with Bio-Techne Corporation (NASDAQ: TECH), a global leading provider of innovative reagents, instruments, and solutions for life-science research and clinical diagnostics. The partnership significantly expands global access to Spear Bio’s groundbreaking SPEAR UltraDetect™ immunoassays, focusing initially on the",
      "url": "https://finnhub.io/api/news?id=bf3be4c7691874495c8529b80e789aec9f66aa62fc867c8ddfb0b92a4d675e0a"
    }
  },
  {
    "ts": null,
    "headline": "Bio-Techne Corporation and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultras sensitive Biomarker Detection",
    "summary": "Bio-Techne Corporation announced a strategic partnership to distribute Spear Bio's next-generation ultrasensitive immunoassays, enabling the detection of low-abundance biomarkers in neurology. Under...",
    "url": "https://finnhub.io/api/news?id=095cb39f49b7c683009ae992483ff279bcc52ea5c2cf9825b829632b4bdc969b",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752580282,
      "headline": "Bio-Techne Corporation and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultras sensitive Biomarker Detection",
      "id": 135948034,
      "image": "",
      "related": "TECH",
      "source": "Finnhub",
      "summary": "Bio-Techne Corporation announced a strategic partnership to distribute Spear Bio's next-generation ultrasensitive immunoassays, enabling the detection of low-abundance biomarkers in neurology. Under...",
      "url": "https://finnhub.io/api/news?id=095cb39f49b7c683009ae992483ff279bcc52ea5c2cf9825b829632b4bdc969b"
    }
  },
  {
    "ts": null,
    "headline": "Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection",
    "summary": "Bio-Techne Corporation (NASDAQ: TECH) today announced a strategic partnership to distribute Spear Bio's next-generation ultrasensitive immunoassays, enabling the detection of low-abundance biomarkers in neurology. Under the agreement, Bio-Techne will distribute Spear Bio's ultrasensitive immunoassays for challenging low-abundance biomarkers, including key Alzheimer's disease biomarkers such as phosphorylated tau 217 (pTau 217), GFAP, neurofilament light (Nf-L), and phosphorylated tau 231 (pTau 2",
    "url": "https://finnhub.io/api/news?id=730742b55f0fbc87debfdbb606d0bfe46e8dfff6066f74172b8bf355eac2f8e3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1752577200,
      "headline": "Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection",
      "id": 135966610,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "TECH",
      "source": "Yahoo",
      "summary": "Bio-Techne Corporation (NASDAQ: TECH) today announced a strategic partnership to distribute Spear Bio's next-generation ultrasensitive immunoassays, enabling the detection of low-abundance biomarkers in neurology. Under the agreement, Bio-Techne will distribute Spear Bio's ultrasensitive immunoassays for challenging low-abundance biomarkers, including key Alzheimer's disease biomarkers such as phosphorylated tau 217 (pTau 217), GFAP, neurofilament light (Nf-L), and phosphorylated tau 231 (pTau 2",
      "url": "https://finnhub.io/api/news?id=730742b55f0fbc87debfdbb606d0bfe46e8dfff6066f74172b8bf355eac2f8e3"
    }
  }
]